Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 330

1.

The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient Data.

Timbergen MJM, Colombo C, Renckens M, Kim HS, Rosmalen JV, Salas S, Mullen JT, Colombo P, Nishida Y, Wiemer EAC, Verhoef C, Sleijfer S, Gronchi A, Grünhagen DJ.

Ann Surg. 2019 Dec 2. doi: 10.1097/SLA.0000000000003698. [Epub ahead of print]

PMID:
31804402
2.

ASO Author Reflections: A Breach in the Border-Retroperitoneal Sarcoma with an Intraperitoneal Component.

Nizri E, Gronchi A.

Ann Surg Oncol. 2019 Dec;26(Suppl 3):838-839. doi: 10.1245/s10434-019-08002-6. Epub 2019 Oct 25. No abstract available.

PMID:
31654161
3.

CT imaging improves histopathological grading of retroperitoneal leiomyosarcomas.

Mcaddy NC, Hallin M, Strauss D, Smith M, Hayes A, Yusuf S, Moskovic E, Fotiadis N, van Houdt W, Jones RL, Gronchi A, Thway K, Messiou C.

Eur J Surg Oncol. 2019 Oct 10. pii: S0748-7983(19)30888-1. doi: 10.1016/j.ejso.2019.10.007. [Epub ahead of print]

PMID:
31653457
4.

Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.

Frezza AM, Assi T, Lo Vullo S, Ben-Ami E, Dufresne A, Yonemori K, Noguchi E, Siontis B, Ferraro R, Teterycz P, Duffaud F, Ravi V, Vincenzi B, Gelderblom H, Pantaleo MA, Baldi GG, Desar I, Fedenko A, Maki RG, Jones RL, Benjamin RS, Blay JY, Kawai A, Gounder M, Gronchi A, Le Cesne A, Mir O, Czarnecka AM, Schuetze S, Wagner AJ, Adam J, Barisella M, Sbaraglia M, Hornick JL, Meurgey A, Mariani L, Casali PG, Thornton K, Stacchiotti S.

Cancer. 2020 Jan 1;126(1):98-104. doi: 10.1002/cncr.32508. Epub 2019 Sep 19.

PMID:
31536651
5.

Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas.

Frapolli R, Bello E, Ponzo M, Craparotta I, Mannarino L, Ballabio S, Marchini S, Carrassa L, Ubezio P, Porcu L, Brich S, Sanfilippo R, Casali PG, Gronchi A, Pilotti S, D'Incalci M.

Clin Cancer Res. 2019 Sep 3. doi: 10.1158/1078-0432.CCR-19-0976. [Epub ahead of print]

PMID:
31481505
6.

Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study.

Hohenberger P, Bonvalot S, van Coevorden F, Rutkowski P, Stoeckle E, Olungu C, Litiere S, Wardelmann E, Gronchi A, Casali P.

Eur J Cancer. 2019 Oct;120:47-53. doi: 10.1016/j.ejca.2019.07.028. Epub 2019 Aug 31.

PMID:
31479947
7.

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin.

Bello E, Brich S, Craparotta I, Mannarino L, Ballabio S, Gatta R, Marchini S, Carrassa L, Matteo C, Sanfilippo R, Gronchi A, Casali PG, Pilotti S, D'Incalci M, Frapolli R.

Br J Cancer. 2019 Sep;121(6):464-473. doi: 10.1038/s41416-019-0550-2. Epub 2019 Aug 14.

PMID:
31409911
8.

Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft.

Stacchiotti S, Zuco V, Tortoreto M, Cominetti D, Frezza AM, Percio S, Indio V, Barisella M, Monti V, Brich S, Astolfi A, Colombo C, Pasquali S, Folini M, Gounder MM, Pantaleo MA, Collini P, Dei Tos AP, Casali PG, Gronchi A, Zaffaroni N.

Cancers (Basel). 2019 Jul 19;11(7). pii: E1015. doi: 10.3390/cancers11071015.

9.

Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal Prognosis.

Nizri E, Fiore M, Barretta F, Colombo C, Radaelli S, Callegaro D, Sanfilippo R, Sangalli C, Collini P, Stacchiotti S, Casali PG, Miceli R, Gronchi A.

Ann Surg Oncol. 2019 Oct;26(11):3535-3541. doi: 10.1245/s10434-019-07615-1. Epub 2019 Jul 16.

PMID:
31313035
10.

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial.

Bonvalot S, Rutkowski PL, Thariat J, Carrère S, Ducassou A, Sunyach MP, Agoston P, Hong A, Mervoyer A, Rastrelli M, Moreno V, Li RK, Tiangco B, Herraez AC, Gronchi A, Mangel L, Sy-Ortin T, Hohenberger P, de Baère T, Le Cesne A, Helfre S, Saada-Bouzid E, Borkowska A, Anghel R, Co A, Gebhart M, Kantor G, Montero A, Loong HH, Vergés R, Lapeire L, Dema S, Kacso G, Austen L, Moureau-Zabotto L, Servois V, Wardelmann E, Terrier P, Lazar AJ, Bovée JVMG, Le Péchoux C, Papai Z.

Lancet Oncol. 2019 Aug;20(8):1148-1159. doi: 10.1016/S1470-2045(19)30326-2. Epub 2019 Jul 8. Erratum in: Lancet Oncol. 2019 Sep;20(9):e468.

PMID:
31296491
11.

Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas).

Sanfilippo R, Jones RL, Blay JY, Le Cesne A, Provenzano S, Antoniou G, Mir O, Fucà G, Fumagalli E, Bertulli R, Stacchiotti S, Brahmi M, Grosso F, Dufresne A, Hindi N, Sbaraglia M, Gronchi A, Collini P, Dei Tos AP, Casali PG.

Clin Cancer Res. 2019 Sep 1;25(17):5295-5300. doi: 10.1158/1078-0432.CCR-19-0288. Epub 2019 Jun 19.

PMID:
31217199
12.

Personalizing surgical margins in retroperitoneal sarcomas: an update.

Dingley B, Fiore M, Gronchi A.

Expert Rev Anticancer Ther. 2019 Jul;19(7):613-631. doi: 10.1080/14737140.2019.1625774. Epub 2019 Jun 8.

PMID:
31159625
13.

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups.

Gronchi A, Hindi N, Cruz J, Blay JY, Lopez-Pousa A, Italiano A, Alvarez R, Gutierrez A, Rincón I, Sangalli C, Pérez Aguiar JL, Romero J, Morosi C, Sunyach MP, Sanfilippo R, Romagosa C, Ranchere-Vince D, Dei Tos AP, Casali PG, Martin-Broto J.

EClinicalMedicine. 2019 Mar 11;9:35-43. doi: 10.1016/j.eclinm.2019.03.007. eCollection 2019 Mar.

14.

Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments.

Suarez-Kelly LP, Baldi GG, Gronchi A.

Expert Opin Pharmacother. 2019 Aug;20(12):1503-1515. doi: 10.1080/14656566.2019.1618271. Epub 2019 May 28. Review.

PMID:
31136210
15.

Management of complicated tumor response to tyrosine-kinase inhibitors in gastrointestinal stromal tumors.

Tirotta F, Fumagalli E, Colombo C, Morosi C, Barisella M, Radaelli S, Frezza AM, Casali PG, Gronchi A, Fiore M.

J Surg Oncol. 2019 Aug;120(2):256-261. doi: 10.1002/jso.25491. Epub 2019 May 7.

PMID:
31066052
16.

NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.

Brenca M, Stacchiotti S, Fassetta K, Sbaraglia M, Janjusevic M, Racanelli D, Polano M, Rossi S, Brich S, Dagrada GP, Collini P, Colombo C, Gronchi A, Astolfi A, Indio V, Pantaleo MA, Picci P, Casali PG, Dei Tos AP, Pilotti S, Maestro R.

J Pathol. 2019 Sep;249(1):90-101. doi: 10.1002/path.5284. Epub 2019 May 14.

17.

Staging systems and nomograms in soft tissue sarcoma: outcome prediction by categorization or personalization?

Tseng WW, Pasquali S, Hu JS, Menendez LR, Gronchi A.

Chin Clin Oncol. 2019 Oct;8(S1):S12. doi: 10.21037/cco.2019.01.05. Epub 2019 Mar 6. No abstract available.

18.

New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration.

van Houdt WJ, Raut CP, Bonvalot S, Swallow CJ, Haas R, Gronchi A.

Curr Opin Oncol. 2019 Jul;31(4):310-316. doi: 10.1097/CCO.0000000000000535.

PMID:
30893150
19.

Outcome of iliocaval resection and reconstruction for retroperitoneal sarcoma.

Ferraris M, Callegaro D, Barretta F, Fiore M, Radaelli S, Stacchiotti S, Miceli R, Socrate AM, Locati P, Gronchi A.

J Vasc Surg Venous Lymphat Disord. 2019 Jul;7(4):547-556. doi: 10.1016/j.jvsv.2018.10.023. Epub 2019 Feb 18.

PMID:
30792153
20.

Impact of Concomitant Administration of Gastric Acid-Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials.

Mir O, Touati N, Lia M, Litière S, Le Cesne A, Sleijfer S, Blay JY, Leahy M, Young R, Mathijssen RHJ, Van Erp NP, Gelderblom H, Van der Graaf WT, Gronchi A.

Clin Cancer Res. 2019 Mar 1;25(5):1479-1485. doi: 10.1158/1078-0432.CCR-18-2748. Epub 2019 Feb 14.

PMID:
30765389
21.

Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.

Raut CP, Callegaro D, Miceli R, Barretta F, Rutkowski P, Blay JY, Lahat G, Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Pillarisetty VG, Nessim C, Swallow CJ, Bagaria S, Canter R, Mullen J, Gelderblom HJ, Pennacchioli E, van Coevorden F, Cardona K, Fiore M, Fairweather M, Gronchi A.

Clin Cancer Res. 2019 Apr 15;25(8):2664-2671. doi: 10.1158/1078-0432.CCR-18-2700. Epub 2019 Feb 5.

PMID:
30723141
22.

Treatment of Desmoid Tumors in 2019.

Gronchi A, Jones RL.

JAMA Oncol. 2019 Apr 1;5(4):567-568. doi: 10.1001/jamaoncol.2018.6449. No abstract available.

PMID:
30703188
23.

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.

Pasquali S, Pizzamiglio S, Touati N, Litiere S, Marreaud S, Kasper B, Gelderblom H, Stacchiotti S, Judson I, Dei Tos AP, Verderio P, Casali PG, Woll PJ, Gronchi A; EORTC – Soft Tissue and Bone Sarcoma Group.

Eur J Cancer. 2019 Mar;109:51-60. doi: 10.1016/j.ejca.2018.12.009. Epub 2019 Jan 25.

PMID:
30690293
24.

Diagnostic accuracy of percutaneous biopsy in retroperitoneal sarcoma.

Almond LM, Tirotta F, Tattersall H, Hodson J, Cascella T, Barisella M, Marchianò A, Greco G, Desai A, Ford SJ, Gronchi A, Fiore M, Morosi C.

Br J Surg. 2019 Mar;106(4):395-403. doi: 10.1002/bjs.11064. Epub 2019 Jan 24.

PMID:
30675910
25.

Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy.

Pastorino U, Morelli D, Leuzzi G, Rolli L, Suatoni P, Taverna F, Bertocchi E, Boeri M, Sozzi G, Cantarutti A, Corrao G, Gronchi A.

Ann Surg Oncol. 2019 Mar;26(3):869-875. doi: 10.1245/s10434-018-07116-7. Epub 2019 Jan 3.

PMID:
30607764
26.

Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.

Haas RLM, Bonvalot S, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Gladdy R, Jakob J, Szacht M, Fiore M, Chung PW, van Houdt WJ, Raut CP, Gronchi A.

Cancer. 2019 Apr 15;125(8):1290-1300. doi: 10.1002/cncr.31927. Epub 2019 Jan 2.

27.

Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients-A propensity score analysis.

Nizri E, Fiore M, Colombo C, Radaelli S, Callegaro D, Sanfilippo R, Sangalli C, Collini P, Morosi C, Stacchiotti S, Casali PG, Gronchi A.

J Surg Oncol. 2019 Mar;119(3):318-323. doi: 10.1002/jso.25337. Epub 2018 Dec 16.

PMID:
30554403
28.

Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study.

Stacchiotti S, Simeone N, Lo Vullo S, Morosi C, Greco FG, Gronchi A, Barisella M, Collini P, Zaffaroni N, Dagrada GP, Frezza AM, Mariani L, Casali PG.

Eur J Cancer. 2019 Jan;106:225-233. doi: 10.1016/j.ejca.2018.10.024. Epub 2018 Dec 5.

PMID:
30528807
29.

Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study.

Fucà G, Hindi N, Ray-Coquard I, Colia V, Dei Tos AP, Martin-Broto J, Brahmi M, Collini P, Lorusso D, Raspagliesi F, Pantaleo MA, Vincenzi B, Fumagalli E, Gronchi A, Casali PG, Sanfilippo R.

Oncologist. 2019 Jul;24(7):e536-e541. doi: 10.1634/theoncologist.2018-0338. Epub 2018 Dec 5.

PMID:
30518617
30.

ASO Author Reflections: Evolving Concepts for Radiation Therapy in Extremity and Trunk Soft Tissue Sarcoma.

Fiore M, Gronchi A.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):942-943. doi: 10.1245/s10434-018-7052-y. Epub 2018 Nov 12. No abstract available.

PMID:
30421054
31.

Radiation-Induced Sarcoma of the Head and Neck: A Review of the Literature.

Giannini L, Incandela F, Fiore M, Gronchi A, Stacchiotti S, Sangalli C, Piazza C.

Front Oncol. 2018 Oct 17;8:449. doi: 10.3389/fonc.2018.00449. eCollection 2018. Review.

32.

Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.

Callegaro D, Miceli R, Bonvalot S, Ferguson P, Strauss DC, Levy A, Griffin A, Hayes AJ, Stacchiotti S, Le Pèchoux C, Smith MJ, Fiore M, Dei Tos AP, Smith HG, Catton C, Casali PG, Wunder JS, Gronchi A.

Eur J Cancer. 2018 Dec;105:19-27. doi: 10.1016/j.ejca.2018.09.028. Epub 2018 Oct 29.

PMID:
30384013
33.

Surrogate endpoints in advanced sarcoma trials: a meta-analysis.

Savina M, Litière S, Italiano A, Burzykowski T, Bonnetain F, Gourgou S, Rondeau V, Blay JY, Cousin S, Duffaud F, Gelderblom H, Gronchi A, Judson I, Le Cesne A, Lorigan P, Maurel J, van der Graaf W, Verweij J, Mathoulin-Pélissier S, Bellera C.

Oncotarget. 2018 Oct 2;9(77):34617-34627. doi: 10.18632/oncotarget.26166. eCollection 2018 Oct 2.

34.

A call to action: Why sarcoma surgery needs to be centralized.

Raut CP, Bonvalot S, Gronchi A.

Cancer. 2018 Dec 1;124(23):4452-4454. doi: 10.1002/cncr.31749. Epub 2018 Oct 14. No abstract available.

35.

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S, Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugières L, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gaspar N, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hecker-Nolting S, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kager L, Kasper B, Kopeckova K, Krákorová DA, Ladenstein R, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Morland B, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Strauss SJ, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee, PaedCan and ERN EURACAN.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv79-iv95. doi: 10.1093/annonc/mdy310. No abstract available.

36.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv268-iv269. doi: 10.1093/annonc/mdy321. No abstract available.

37.

The Diagnosis and Management of Retroperitoneal Sarcoma.

Dumitra S, Gronchi A.

Oncology (Williston Park). 2018 Sep 15;32(9):464-9.

38.

The evolving role of patient advocates in rare cancers: opportunities and challenges.

Gonzato O, Gronchi A.

Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):1-3. doi: 10.1080/14737167.2019.1526083. Epub 2018 Sep 27. No abstract available.

PMID:
30227750
39.

Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study.

Stacchiotti S, Morosi C, Lo Vullo S, Casale A, Palassini E, Frezza AM, Dinoi G, Messina A, Gronchi A, Cavalleri A, Venturelli E, Morelli D, Pilotti S, Collini P, Brich S, Tamborini E, Mariani L, Casali PG.

Cancer. 2018 Oct 15;124(20):4056-4063. doi: 10.1002/cncr.31685. Epub 2018 Sep 14. Erratum in: Cancer. 2019 Nov 1;125(21):3893.

40.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv267. doi: 10.1093/annonc/mdy320. No abstract available.

41.

Surgical management of retroperitoneal sarcoma and opportunities for global collaboration.

Wang J, Grignol VP, Gronchi A, Luo CH, Pollock RE, Tseng WW.

Chin Clin Oncol. 2018 Aug;7(4):39. doi: 10.21037/cco.2018.07.05. Review.

42.

Staging, nomograms and other predictive tools in retroperitoneal soft tissue sarcoma.

Tattersall HL, Callegaro D, Ford SJ, Gronchi A.

Chin Clin Oncol. 2018 Aug;7(4):36. doi: 10.21037/cco.2018.08.01. Review.

43.

2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma.

Frezza AM, Lee ATJ, Nizri E, Sbaraglia M, Jones RL, Gronchi A, Dei Tos AP, Casali PG.

ESMO Open. 2018 Jun 28;3(4):e000390. doi: 10.1136/esmoopen-2018-000390. eCollection 2018. Review.

44.

Towards the standard use of (neo)adjuvant chemotherapy in selected localised soft tissue sarcoma at high risk of relapse: are we finally getting there?

Gronchi A.

Eur J Cancer. 2018 Sep;101:251-253. doi: 10.1016/j.ejca.2018.06.004. Epub 2018 Jul 13. No abstract available.

PMID:
30017382
45.

Surgical resection as an adjuvant to tyrosine kinase inhibitors in metastatic GIST: Association or causation?/Are we any closer to an answer?

Tattersall HL, Gronchi A.

Eur J Surg Oncol. 2018 Sep;44(9):1287-1288. doi: 10.1016/j.ejso.2018.06.006. Epub 2018 Jun 18. No abstract available.

PMID:
29960769
46.

Minimally Invasive Surgery for Retroperitoneal Sarcoma: Just Because We Can Does Not Mean We Should.

Gronchi A, Crago A, Raut CP.

Ann Surg Oncol. 2018 Aug;25(8):2129-2131. doi: 10.1245/s10434-018-6572-9. Epub 2018 Jun 14. No abstract available.

PMID:
29948424
47.

Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma.

Urbini M, Indio V, Astolfi A, Tarantino G, Renne SL, Pilotti S, Dei Tos AP, Maestro R, Collini P, Nannini M, Saponara M, Murrone L, Dagrada GP, Colombo C, Gronchi A, Pession A, Casali PG, Stacchiotti S, Pantaleo MA.

Int J Mol Sci. 2018 Jun 23;19(7). pii: E1855. doi: 10.3390/ijms19071855.

48.

Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis.

Colombo C, Urbini M, Astolfi A, Collini P, Indio V, Belfiore A, Paielli N, Perrone F, Tarantino G, Palassini E, Fiore M, Pession A, Stacchiotti S, Pantaleo MA, Gronchi A.

Genes Chromosomes Cancer. 2018 Oct;57(10):495-503. doi: 10.1002/gcc.22644. Epub 2018 Aug 20.

PMID:
29901254
49.

The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and Trunk.

Gronchi A, Jones RL.

JAMA Oncol. 2018 Sep 1;4(9):1167-1168. doi: 10.1001/jamaoncol.2018.1392. No abstract available.

PMID:
29879269
50.

Consistent Margin-Status Reporting in Soft Tissue Sarcoma Is Essential to Establish Risk-Adapted Strategies Integrating Biology and Histotype in Perioperative Treatments.

Levy A, Bonvalot S, Callegaro D, Botticella A, Le Cesne A, Gronchi A, Le Péchoux C.

J Clin Oncol. 2018 Aug 1;36(22):2357-2358. doi: 10.1200/JCO.2018.78.6657. Epub 2018 Jun 7. No abstract available.

PMID:
29878864

Supplemental Content

Loading ...
Support Center